Skip to content

Apotheek Donné

Active
Private limited companyfounded 2019active for 7 yearsSteenweg op Gierle 17, 2300 Turnhout, BelgiumKBO/BCE: BE 0719.888.270
Summary

Apotheek Donné has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €65,273 and a net result of €31,090. Equity has been growing by about 3.9% per year since 2019. Its solvency ranks better than 42% of 22,774 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).

Overview

Official details

Source: KBO
Status
Active since 06-02-2019 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.285.032.364 2300 Turnhout, since 06-02-2019
Financial year end
31 December
Peppol
Reachable since 21-10-2026

Board and ownership

Board
  • DONNE MARGARETHADirector

Financial position

84 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.5%
Annual accounts 2025
Gross margin
€125,789
▼ 5.0%
Turnover
≈ €400,000
estimated
Profit
€31,090
▼ 20.3%
Equity
€65,273
▲ 90.9%
Total assets
€268,167
▼ 12.4%
Employees on 31-12-2025
1
=
Score breakdownraises riskSector: Retail trade (NACE 47)Founded in 2019Size: total assets €268,167lowers riskLiquidity: current ratio 0.89, cash €72,376Show the evidence

Checked score

Score 2025
84 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 62% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 49+13
equity 24.3% of total assets
Liquidity 43+6
short-term debt 75.7% · cash 27.0%
Profitability 83-2
return on assets 11.6%
Bankruptcy probability within 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,281 companies, NACE 47, micro)
Last 24 months 12-2024: 0.6% 01-2025: 0.6%● unchanged vs 12-2024 02-2025: 0.6%● unchanged vs 01-2025 03-2025: 0.6%● unchanged vs 02-2025 04-2025: 0.7%▲ +0.1 percentage points vs 03-2025 05-2025: 0.7%● unchanged vs 04-2025 06-2025: 0.6%▼ -0.1 percentage points vs 05-2025 07-2025: 0.7%▲ +0.1 percentage points vs 06-2025 08-2025: 0.6%▼ -0.1 percentage points vs 07-2025 09-2025: 0.6%● unchanged vs 08-2025 10-2025: 0.6%● unchanged vs 09-2025 11-2025: 0.6%● unchanged vs 10-2025 12-2025: 0.6%● unchanged vs 11-2025 01-2026: 0.6%● unchanged vs 12-2025 02-2026: 0.6%● unchanged vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.6%● unchanged vs 04-2026 06-2026: 0.6%● unchanged vs 05-2026 07-2026: 0.7%▲ +0.1 percentage points vs 06-2026 08-2026: 0.9%▲ +0.2 percentage points vs 07-2026 09-2026: 1.1%▲ +0.2 percentage points vs 08-2026highest value 10-2026: 0.5%▼ -0.6 percentage points vs 09-2026lowest value 11-2026: 0.5%● unchanged vs 10-2026lowest value
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.89 (0.78 in 2024), below 1. Short-term debt is 75.7% and cash 27% of total assets. 75.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 40% of them on solvency, 41% on liquidity, 77% on profitability and 91% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 0.89, cash €72,376
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Founded in 2019
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Size: total assets €268,167
Companies of this size fail more often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-06-2026, 39 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
39 days early
2024
20 days early
2023
42 days early
2022
40 days early
2021
39 days early
2020
25 days early
2019
15 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 31 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 22 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 80% of companies in retail tradesector median €5,083 · 22,756 companies €31,090 View
  • Positive: Always filed on timeaccounts within the deadline every year 7 years View
  • Positive: 7 profitable years in a rowprofit 2025: €31,090 7 years View

Recent changes

  1. · Gazette deed Incorporation
All 9 events

Comparable companies

These companies have the same main activity as Apotheek Donné: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €235,000 and €311,000, founded between 2017 and 2018.

CompanyTotal assetsGross margin
Apotheek Donné Turnhout€268,167€125,789
CK Pharma Support Westerlo€263,572€117,605
PHARMACIE DE BUVRINNES Binche€269,171€132,143
Pharmacie Keereman Schaarbeek€235,291€114,947
PHARMACIE DU MIDI Sint-Gillis (bij-Brussel)€282,032€124,746
PHARMA LEYENS Liège€311,356€113,575
PHARM.ASSY Wemmel€268,957€101,093
Full comparison

Key facts about Apotheek Donné

What is the company number of Apotheek Donné?
The company number of Apotheek Donné is 0719.888.270. The VAT number is the same number with BE in front: BE 0719.888.270.
Where is Apotheek Donné based?
The registered office is at Steenweg op Gierle 17, 2300 Turnhout.Company details
What does Apotheek Donné do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Donné?
The legal form of Apotheek Donné is Private limited company (BV).
When was Apotheek Donné founded?
Apotheek Donné was founded on 06-02-2019.
Is Apotheek Donné still active?
Yes, Apotheek Donné is an active enterprise in the KBO register.
How many employees does Apotheek Donné have?
Apotheek Donné had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Apotheek Donné fall under?
In its 2025 annual accounts, Apotheek Donné states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of Apotheek Donné?
The turnover in financial year 2025 is ≈ €400,000. This figure is estimated from the gross margin of €125,789 and 32 comparable companies (NACE 477). It probably lies between €270,000 and €780,000.
Is Apotheek Donné profitable?
In financial year 2025, Apotheek Donné made a profit of €31,090.
Where can I find the annual accounts of Apotheek Donné?
Apotheek Donné filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Donné due?
Apotheek Donné must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.